Neurocrine Biosciences NBIX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2025, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's interest coverage?
- Neurocrine Biosciences (NBIX) reported interest coverage of 101× in Q1 2024.
- How has Neurocrine Biosciences's interest coverage changed year-over-year?
- Neurocrine Biosciences's interest coverage increased by 329.3% year-over-year, from 23.5× to 101×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.